Small Airways Obstruction and Mortality
CHEST · 2024-10 · 166 (4) · 712-720
DOI: 10.1016/j.chest.2024.04.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2024-10. Verfasst von Valentina Quintero Santofimio und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: vq20@imperial.ac.uk. Hauptthemen laut MEDLINE: Spirometry, Airway Obstruction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Colt Foundation.
Abstract (Originalsprache)
BACKGROUND: Small airways obstruction (SAO) is common in general populations. It has been associated with respiratory symptoms, cardiometabolic diseases, and progression to COPD over time. Whether SAO predicts mortality is largely unknown. RESEARCH QUESTION: Is spirometry-defined SAO associated with increased mortality? METHODS: Data were analyzed from 252,877 adult participants, aged 40 to 69 years at baseline, in the UK Biobank who had provided good-quality spirometry measurements. SAO was defined as the ratio of the forced expiratory volume in 3 s to the forced expiratory volume in 6 s less than the lower limit of normal. SAO was considered to be isolated if present when the FEV1/forced expiratory volume in 6 s ratio was normal (ie, greater than the lower limit of normal). A multivariable Cox regression model was used to assess the association of SAO, and isolated SAO, with all-cause and disease-specific mortality. Sex differences were investigated in these associations, and the primary analysis was repeated, excluding those who ever smoked. All models were adjusted for potential confounders such as sex, BMI, smoking status, smoking pack-years, assessment center, Townsend deprivation index, and ethnicity. RESULTS: A total of 59,744 participants with SAO were identified, of whom 24,004 had isolated SAO. A total of 5,009 deaths were reported over a median of 12.8 years of follow-up. Participants with SAO had increased all-cause (hazard ratio [HR], 1.31; 95% CI, 1.26-1.36), cardiovascular (HR, 1.39; 95% CI, 1.29-1.51), respiratory (HR, 2.20; 95% CI, 1.92-2.51), and neoplasm (HR, 1.23; 95% CI, 1.17-1.29) mortality risk. These associations were not modified by sex. However, in those who never smoked, only respiratory and cardiovascular mortality risk was associated with SAO. Isolated SAO was also associated with an increased mortality risk (HR, 1.14; 95% CI, 1.07-1.20). INTERPRETATION: Individuals with SAO have an increased risk of all-cause and disease-specific mortality. Further studies are needed to determine whether SAO causes mortality or is a marker of underlying disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: vq20@imperial.ac.uk.
- National Heart and Lung Institute, Imperial College London, London, United Kingdom.
- National Heart and Lung Institute, Imperial College London, London, United Kingdom; NIHR Imperial Biomedical Research Centre, London, United Kingdom.
Förderung
- Colt Foundation
Zitieren
APA
Quintero Santofimio, V., Knox-Brown, B., Potts, J., Bartlett-Pestell, S., Feary, J., & Amaral, A. F. S. (2024). Small Airways Obstruction and Mortality. CHEST, 166(4), 712-720. https://doi.org/10.1016/j.chest.2024.04.016
Vancouver
Quintero Santofimio V, Knox-Brown B, Potts J, Bartlett-Pestell S, Feary J, Amaral AFS. Small Airways Obstruction and Mortality. CHEST. 2024;166(4):712-720. doi:10.1016/j.chest.2024.04.016
BibTeX
@article{QuinteroSantofimio2024,
author = {Quintero Santofimio, Valentina and Knox-Brown, Ben and Potts, James and Bartlett-Pestell, Samuel and Feary, Johanna and Amaral, Andre F S},
title = {Small Airways Obstruction and Mortality},
journal = {CHEST},
year = {2024},
volume = {166},
number = {4},
pages = {712--720},
doi = {10.1016/j.chest.2024.04.016}
}
EUVIMED